Full Breakdown
NHS Sterilisation Policy Overturned After Ombudsman Ruling
5/2/2026, 6:57:59 AM
Ombudsman Ruling Overturns Sterilisation Funding Denial
Leah Spasova, an Oxfordshire psychologist, was denied NHS funding for female sterilisation by the Buckinghamshire, Oxfordshire and Berkshire West Integrated Care Board (BOB ICB) on grounds of potential regret and cost-effectiveness. After ten years of appeals she complained to Parliamentary and Health Service Ombudsman, which in May 2026 ruled ICB’s policy “unfair, inconsistent and based on subjective reasoning,” and ordered a review of commissioning and complaints processes.
Gender Disparity in NHS Sterilisation Funding
The ICB funded vasectomies for men without a regret test, while refusing funding for tubal ligation. Clinical guidance recommends counselling instead of blanket refusal for women. A 2024 advisory committee covering six south-east ICBs, including BOB ICB, flagged the gender disparity and advised that regret no longer be a refusal criterion.
Key Dates
2017 – Committee notes £1,000 cost for female sterilisation.
2023 – Spasova writes to the trust about postcode-lottery funding.
2024 – Advisory committee reviews policy, recommends funding for women.
May 2026 – Ombudsman rules; ICB apologises and adopts a new policy.
Cost Comparison
NHS female sterilisation costs ~£1,000; private clinics charge £2,000-£4,000. The contraceptive pill for 20 years totals £5,289.60 (£22.04 per month). The ombudsman highlighted inconsistent cost-effectiveness reasoning between male and female procedures.
Official Reactions
Paula Sussex, chief of the Parliamentary and Health Service Ombudsman, said the case shows the power of the patient voice and warned that similar systemic issues may exist across the NHS. Thames Valley ICB, successor to BOB ICB, accepted the findings, apologized and introduced a policy to fund female sterilisation for patients meeting the criteria. The 2024 advisory committee advised that regret should no longer justify denial.
Spasova’s Critique
Spasova argued the regret test transferred decision-making about her body to the board, calling the policy “absolutely discriminatory” and harmful to women’s health. She noted that, even after the ruling, women must still prove failure of long-acting contraception before qualifying for sterilisation, a requirement she likened to a “therapeutic-trial” imposed on men seeking vasectomies.
Remaining Gaps
The ICB says the new policy eliminates the regret barrier, yet Spasova says practical obstacles remain and the rollout timeline is unclear.
Key Quotes
- “The issue highlighted in Leah’s case about the commissioning and managing of services by ICBs is not an isolated one.” — Paula Sussex, Parliamentary and Health Service Ombudsman
- “This case shows the power of the patient voice.” — Paula Sussex, Parliamentary and Health Service Ombudsman
- “Rejecting my application for sterilisation on the basis of regret means they were taking on liability for my feelings.” — Leah Spasova, Psychologist
- “Policies like this are damaging for women's healthcare and women's access to health services - it's absolutely discriminatory.” — Leah Spasova, Psychologist
Future Outlook
Thames Valley ICB will monitor the policy’s rollout while the ombudsman plans a wider review of NHS commissioning to detect any further gender-based inequities.
